There is considerable interest and the application in medicine of the metals gallium, indium, and gadolinium. Radioisotopes of gallium and indium are widely used in medical imaging while gadolinium has been utilized as a paramagnetic contrast agent in conjunction with nuclear magnetic resonance imaging. In this proposal it is planned to design, synthesize and study new, improved chelating agents for the complexation of these metal ions. Chelating agents for gallium and indium will be designed with maximum thermodynamic stability by use with ligands of donor groups highly selective for these trivalent metal ions, and by incorporating these groups into macrocyclic rings. Site direction of the chelates will be achieved by moderating their lipid solubility and membrane permeability with alkyl groups and other substituents. The chelating groups will be functionalized with several types of linkages for achieving site specificity by covalent attachment to antibodies. Magnetic resonance contrast agents will be developed with ligands for Fe(III) and Gd(III) which, while designed for maximum stability will allow coordination of inner sphere water by the omission of one or more ligand donor groups from the standard ligands used for these metal ions. The stability constants of these new ligands will be determined and the rate of exchange with plasma proteins measured. In this way, both the equilibrium and kinetic stability of the complexes of these ligands will be determined. The biodistribution of labeled compounds will be determined in rats, hamsters and in some case primates. Promising ligands will be attached to monoclonal antibodies and evaluated in both in vitro and in vivo models. The gadolinium complexes will be studied in vitro and in vivo for potential uses as paramagnetic NMR contrast agents. The synthesis, characterization and physicochemical studies will be carried out at Texas A&M University with non-radioactive isotopes while in vitro and in vivo evaluation of the pharmaceutical preparations will be carried out at Washington University.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA042925-07
Application #
2091012
Study Section
Diagnostic Radiology Study Section (RNM)
Project Start
1986-07-01
Project End
1997-01-31
Budget Start
1994-04-01
Budget End
1995-01-31
Support Year
7
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Washington University
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Sun, Xiankai; Kim, Joonyoung; Martell, Arthur E et al. (2004) In vivo evaluation of copper-64-labeled monooxo-tetraazamacrocyclic ligands. Nucl Med Biol 31:1051-9
Sun, Xiankai; Wuest, Melinda; Kovacs, Zoltan et al. (2003) In vivo behavior of copper-64-labeled methanephosphonate tetraaza macrocyclic ligands. J Biol Inorg Chem 8:217-25
Sun, Xiankai; Wuest, Melinda; Weisman, Gary R et al. (2002) Radiolabeling and in vivo behavior of copper-64-labeled cross-bridged cyclam ligands. J Med Chem 45:469-77
Reichert, D E; Norrby, P O; Welch, M J (2001) Molecular modeling of bifunctional chelate peptide conjugates. 1. Copper and indium parameters for the AMBER force field. Inorg Chem 40:5223-30
Sun, Y; Martell, A E; Reibenspies, J H et al. (2000) Synthesis and characterization of racemic mixture and meso isomers of bis(trans-2-aminocyclohexyl)aminepentaacetic acid and the stabilities of their Gd(III) complexes. Inorg Chem 39:1480-6
Cutler, C S; Wuest, M; Anderson, C J et al. (2000) Labeling and in vivo evaluation of novel copper(II) dioxotetraazamacrocyclic complexes. Nucl Med Biol 27:375-80
Deal, K A; Cristel, M E; Welch, M J (1998) Cellular distribution of 111In-LDTPA galactose BSA in normal and asialoglycoprotein receptor-deficient mouse liver. Nucl Med Biol 25:379-85
Jones-Wilson, T M; Deal, K A; Anderson, C J et al. (1998) The in vivo behavior of copper-64-labeled azamacrocyclic complexes. Nucl Med Biol 25:523-30
Deal, K A; Welch, M J (1997) Effect of stereochemistry on the clearance mechanism of 111In(III)-labeled D- or L-benzyldiethylenetriaminepentaacetic acid. J Med Chem 40:3986-9
Sun, Y; Anderson, C J; Pajeau, T S et al. (1996) Indium (III) and gallium (III) complexes of bis(aminoethanethiol) ligands with different denticities: stabilities, molecular modeling, and in vivo behavior. J Med Chem 39:458-70

Showing the most recent 10 out of 28 publications